Annual report pursuant to Section 13 and 15(d)

Stockholders' (Deficit) Equity - Additional Information (Details)

v3.24.1
Stockholders' (Deficit) Equity - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 14, 2023
Apr. 19, 2023
Dec. 31, 2023
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]        
Net proceeds from offering     $ 6,431,612  
Maestro Health LLC | Debt Seller        
Subsidiary, Sale of Stock [Line Items]        
Payment on net proceeds of offering until such time as purchase price paid in full   $ 2,294,751    
Percentage of payment on net proceeds of offering until such time as purchase price paid in full   35.00%    
Common Stock [Member]        
Subsidiary, Sale of Stock [Line Items]        
Number of shares issued [1]     1,850,000  
Shares issued to vendors in exchange for services (in shares) [1]     25,000 9,375
Public Offering        
Subsidiary, Sale of Stock [Line Items]        
Number of shares issued   1,850,000    
Gross proceeds from offering   $ 7,400,000    
Net proceeds from offering   $ 6,400,000    
Price per share   $ 4    
Private Placement        
Subsidiary, Sale of Stock [Line Items]        
Common stock, shares issued 150,000      
[1] Reflects 1-for-4 reverse stock split that became effective June 29, 2023. See Note 1 to the consolidated financial statements.